Maven Bio YC Application

Summer 2023Active

Maven Bio went through Y Combinator in the Summer 2023 batch as a B2B company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Summer 2023
Industry: B2B
Team size: 8
Status: Active
Launched: 2023

Founders

Michael BradyFounder
Arjun MurthyFounder

What Maven Bio does

At Maven Bio, we’re transforming BioPharma knowledge work by pairing domain-specific AI with curated industry data - letting consultants, investors, and corporate teams move from question to decision with less manual work. Our integrated BioPharma-specific platform features four flagship modules: • Maven Workflows: Monitor Maven's domain-specific AI through structured research tasks - step by step - and finalize results with confidence. • Maven Atlas: Access hundreds of pre-built indication landscapes, or generate custom ones on demand for in-depth insights. • Maven Compass: Build precise lists of companies, drugs, trials, or documents with advanced filters - move faster with AI-driven filter suggestions. • Maven Assistant: Get instant answers to your BioPharma questions, complete with direct links to primary sources. Stop burning hours on manual data hunts. Maven Bio’s continuously updated database and collaborative AI features empower you to focus on strategic decisions. We offer usage-based pricing and usage-restricted trials, plus custom solutions for unique data sources or specialized workflows. Trusted by life science consultants, BD teams, and investors worldwide, Maven Bio delivers faster, deeper insights. Book a call to learn how our purpose-built AI can transform your research and accelerate your success.

Maven Bio's YC application, reconstructed

Y Combinator application

Maven Bio, Summer 2023 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Maven Bio

Describe what your company does in 50 characters or less.

The AI Platform for Life Sciences Intelligence

What is your company going to make? Please describe your product and what it does or will do.

We build an AI platform focused on BioPharma research. Our product combines domain-specific AI with curated datasets to help consultants, investors, and corporate teams quickly find reliable insights on drugs, trials, companies, and indications. It includes four main modules: structured workflows to monitor AI-driven research, pre-built and custom indication maps, AI-assisted filtering for lists, and a bio-pharma question-answering assistant.

Where do you live now, and where would the company be based after YC?

We live in Boston, MA and the company is based here and will remain so after YC.

Explain your decision regarding location.

Boston has strong biotech and pharma hubs and access to domain experts. Being here helps us stay close to early customers and industry partners.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real Maven Bio YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Maven Bio's public data (launch notes, founder backgrounds, product description). It shows how a company like Maven Bio would present itself to YC, not the text they submitted.